Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study.
Guida A, Gili A, Mosillo C, Maruzzo M, Lai E, Pierantoni F, Bimbatti D, Basso U, Fornarini G, Rebuzzi SE, Calabrò F, Cerbone L, Caserta C, Sirgiovanni G, Serafin D, Caffo O, Scagliarini S, Bracarda S. Guida A, et al. Among authors: maruzzo m. Clin Genitourin Cancer. 2024 Sep 14;22(6):102225. doi: 10.1016/j.clgc.2024.102225. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39405768
Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group.
Toss A, Piombino C, Quarello P, Trama A, Mascarin M, Lambertini M, Canesi M, Incorvaia L, Milano GM, Maruzzo M, Perrone F, Peccatori F, Ferrari A. Toss A, et al. Among authors: maruzzo m. Eur J Cancer. 2024 Nov;212:115042. doi: 10.1016/j.ejca.2024.115042. Epub 2024 Sep 26. Eur J Cancer. 2024. PMID: 39362174 Free article. Review.
Rogaratinib Plus Atezolizumab in Cisplatin-Ineligible Patients With FGFR RNA-Overexpressing Urothelial Cancer: The FORT-2 Phase 1b Nonrandomized Clinical Trial.
Sweis RF, Gajate P, Morales-Barrera R, Lee JL, Necchi A, de Braud F, Penel N, Grünwald V, Maruzzo M, Meran J, Ishida TC, Bao W, Zhou Y, Ellinghaus P, Rosenberg JE. Sweis RF, et al. Among authors: maruzzo m. JAMA Oncol. 2024 Sep 19;10(11):1565-70. doi: 10.1001/jamaoncol.2024.3900. Online ahead of print. JAMA Oncol. 2024. PMID: 39298147 Free PMC article.
Subcutaneous versus intravenous nivolumab for renal cell carcinoma.
Albiges L, Bourlon MT, Chacón M, Cutuli HJ, Chuken YAL, Żurawski B, Mota JM, Magri I, Burotto M, Luz M, de Menezes J, Ruiz EPY, Fu S, Richardet M, Valderrama BP, Maruzzo M, Bracarda S, Breckenridge M, Vezina HE, Rathod D, Yu Z, Zhao Y, Dixon M, Perumal D, George S. Albiges L, et al. Among authors: maruzzo m. Ann Oncol. 2024 Sep 15:S0923-7534(24)03996-6. doi: 10.1016/j.annonc.2024.09.002. Online ahead of print. Ann Oncol. 2024. PMID: 39288844 Free article.
Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM).
Berardi R, Parisi A, Maruzzo M, Bellani M, Beretta GD, Boldrini M, Cavanna L, Gori S, Iannelli E, Mancuso AM, Marinelli M, Martinella V, Musso M, Papa R, Russo A, Tarantino V, Taranto M, Cinieri S. Berardi R, et al. Among authors: maruzzo m. Support Care Cancer. 2024 Aug 26;32(9):613. doi: 10.1007/s00520-024-08786-8. Support Care Cancer. 2024. PMID: 39222131 Free PMC article.
Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney.
Giudice GC, Maruzzo M, Verzoni E, Procopio G, Bimbatti D, Sepe P, Maines F, Grillone F, Cavo A, Santoni M, Cordua N, Pecoraro G, Prati V, Napoli MD, Ollari E, Caruso G, Simoni N, Campobasso D, Buti S. Giudice GC, et al. Among authors: maruzzo m. Clin Genitourin Cancer. 2024 Oct;22(5):102186. doi: 10.1016/j.clgc.2024.102186. Epub 2024 Aug 2. Clin Genitourin Cancer. 2024. PMID: 39179427 Free article.
A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study.
Anpalakhan S, Banna GL, Rebuzzi SE, Fornarini G, Maruzzo M, Zucali PA, Catalano F, Antonj L, Tudini M, Fratino L, Malgeri A, Rescigno P, Signori A, Acunzo A, Silini EM, Mazzaschi G, Buti S. Anpalakhan S, et al. Among authors: maruzzo m. Immunotherapy. 2024;16(14-15):963-973. doi: 10.1080/1750743X.2024.2382666. Epub 2024 Aug 6. Immunotherapy. 2024. PMID: 39105621
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.
Catalano M, Rebuzzi SE, Maruzzo M, De Giorgi U, Buti S, Galli L, Fornarini G, Zucali PA, Claps M, Chiellino S, Zampiva I, Pipitone S, Ricotta R, Sorarù M, Mollica V, Tudini M, Fratino L, Prati V, Caffo O, Atzori F, Morelli F, Prati G, Nolè F, Vignani F, Cavo A, Di Napoli M, Malgeri A, Naglieri E, Signori A, Banna GL, Rescigno P, Cerbone L, Antonuzzo L, Roviello G. Catalano M, et al. Among authors: maruzzo m. Front Immunol. 2024 Jul 5;15:1361010. doi: 10.3389/fimmu.2024.1361010. eCollection 2024. Front Immunol. 2024. PMID: 39034992 Free PMC article.
141 results